Israel Englander Genfit S.A. Put Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GNFT
# of Institutions
8Shares Held
54.9KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY27.4KShares$103,9210.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il18.8KShares$71,1110.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P74.64KShares$17,5810.0% of portfolio
-
Ubs Group Ag4.08KShares$15,4660.0% of portfolio
-
Principal Securities, Inc. Des Moines, IA24Shares$900.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $189M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...